LncRNA AC104699.1.1 is down-regulated in ovarian cancer. It could significantly divide the late-stage patients into high- and low-risk groups. Moreover, the expression level of AC104699.1.1 is associated with a decreased risk of survival. Low-risk groups always have higher expression levels of AC104699.1.1 than the high-risk. In addition, AC104699.1.1 is significantly associated with patient progression-free survival. Besides, AC104699.1.1 is involved in immune- and cell cycle-associated processes (1).
|LncRNA||tissue||cancer type||expression level||oncogene/suppress gene||pathway||binding gene/factor||associated gene/factor||proliferation||apoptosis||migration||EMT||invasion||metastasis||prognosis||tag||PMID|
|0||AC104699.1.1||ovary||ovarian cancer||down||TS||immune-associated genes||+||26631459|
Expression profile in human body map
Expression profile in TCGA